Downregulation of Cystine Transporter xc– by Irinotecan in Human Head and Neck Cancer FaDu Xenograft...
Downregulation of Cystine Transporter xc– by Irinotecan in Human Head and Neck Cancer FaDu Xenografts
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background: The purpose of this study was: (1) to document the critical requirement of cystine for growth of human tumor cells in vitro, and (2) to determine the effect of the anticancer agent irinotecan on the cystine transporter x c – in head and neck FaDu xenografts. Methods: Cell growth was measured by sulforhodamine B assay. xCT protein, gluta...
Alternative Titles
Full title
Downregulation of Cystine Transporter xc– by Irinotecan in Human Head and Neck Cancer FaDu Xenografts
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_645274628
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_645274628
Other Identifiers
ISSN
0009-3157,1421-9794
E-ISSN
1421-9794
DOI
10.1159/000316334
